Modafinil
Sleep Initiation and Maintenance Disorders
VA Palo Alto Health Care SystemSmall moleculePhase 4 / ApprovedDormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Sleep Initiation and Maintenance Disorders cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TENOFOVIR DISOPROXIL FUMARATE Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
(±)-FTC Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
ZOLPIDEM Astellas Pharma Inc | Phase 3 | BB |
Suvorexant Merck Sharp & Dohme LLC | Phase 3 | BB |
fk199b Astellas Pharma Inc | Phase 3 | BB |
View all 12 →
Same molecule, other indications
Modafinil is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →